Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rare Encouragement Offered

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Jun 15, 2024 12:54pm

174 Views

Post# 36090578

RE:RE:RE:RE:Rare Encouragement Offered

Interesting. That doesn't seem very likely or intentional... but I haven't really thought much about it. Perhaps if something material is said or talked about (even if by mistake), I suppose the company could always request a trading halt before the next morning (with news pending) until they have had time to put an appropriate news release together.

<< Previous

Bullboard Posts

Next >>

A guide to understanding technical analysis for small-cap stocks